Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules
Clinical trial NCT03509883 · COMPLETED
Trial details
- NCT number
- NCT03509883
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2018-06-15
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.